Treatment of brain metastasis from lung cancer

Progress in Neurological Surgery

Volumn 25, Issue , 2012, Pages 148-155

  Kawabe, Takuya ^a,b   Phi, Ji Hoon ^d   Yamamoto, Masaaki ^a,c   Kim, Dong Gyu ^d   Barfod, Bierta E ^a   Urakawa, Yoichi ^a  

^a HITACHI LTD   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN TUMOR; CANCER STAGING; CLASSIFICATION; HUMAN; LUNG TUMOR; METASTASIS; METHODOLOGY; NEUROSURGERY; PATHOLOGY; PROGNOSIS; RADIOSURGERY; REVIEW; SKULL IRRADIATION;

BRAIN NEOPLASMS; CRANIAL IRRADIATION; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; NEUROSURGERY; PROGNOSIS; RADIOSURGERY;

EID: 84860820491     PISSN: 00796492     EISSN: 16623924     Source Type: Book Series    
DOI: 10.1159/000331188     Document Type: Article

References (45)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Meyers CA, Smith JA, Bezjak A, et al: Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 2004;22:157-165.
3. Langer CJ, Mehta MP: Current management of brain metastases, with a focus on systemic options. J Clin Oncol 2005;23:6207-6219.
4. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE: Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004;22:2865-2872.
5. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A: Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002;94:2698-2705.
6. Kamar FG, Posner JB: Brain metastases. Semin Neurol 2010;30:217-235.
7. Smedby KE, Brandt L, Backlund ML, Blomqvist P: Brain metastases admissions in Sweden between 1987 and 2006. Br J Cancer 2009;101:1919-1924.
8. Gaspar L, Scott C, Rotman M, et al: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-751.
9. Patchell RA, Tibbs PA, Walsh J W, et al: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
10. Haie-Meder C, Pellae-Cosset B, Laplanche A, et al: Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases. Radiother Oncol 1993;26:111-116.
11. Komarnicky LT, Phillips TL, Martz K, Asbell S, Isaacson S, Urtasun R: A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 1991;20:53-58.
12. Murray KJ, Scott C, Greenberg HM, et al: A randomized phase III study of accelerated hyperfrac-tionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997;39:571-574.
13. Ricciardi S, de Marinis F: Multimodality management of non-small cell lung cancer patients with brain metastases. Curr Opin Oncol 2010;22:86-93.
14. Khuntia D, Brown P, Li J, Mehta MP: Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 2006;24:1295-1304.
15. Zabel A, Debus J: Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy. Lung Cancer 2004;45(suppl 2):S247-S252.
16. DeAngelis LM, Mandell LR, Thaler HT, et al: The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 1989;24:798-805.
17. Chang EL, Wefel JS, Hess KR, et al: Neurocognition in patients with brain metastases treated with radio-surgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009;10:1037-1044.
18. Bindal RK, Sawaya R, Leavens ME, Lee JJ: Surgical treatment of multiple brain metastases. J Neurosurg 1993;79:210-216.
19. Nakagawa H, Miyawaki Y, Fujita T, et al: Surgical treatment of brain metastases of lung cancer: retrospective analysis of 89 cases. J Neurol Neurosurg Psychiatry 1994;57:950-956.
20. Koutras AK, Marangos M, Kourelis T, et al: Surgical management of cerebral metastases from non-small cell lung cancer. Tumori 2003;89:292-297.
21. Billing PS, Miller DL, Allen MS, Deschamps C, Trastek VF, Pairolero PC: Surgical treatment of primary lung cancer with synchronous brain metastases. J Thorac Cardiovasc Surg 2001;122:548-553.
22. Chidel MA, Suh JH, Greskovich JF, Kupelian PA, Barnett GH: Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis. Radiat Oncol Investig 1999; 7:313-319.
23. Andrews D W, Scott CB, Sperduto PW, et al: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004;363:1665-1672.
24. Aoyama H, Shirato H, Tago M, et al: Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006;295:2483-2491.
25. Jawahar A, Matthew RE, Minagar A, et al: Gamma knife surgery in the management of brain metastases from lung carcinoma: a retrospective analysis of survival, local tumor control, and freedom from new brain metastasis. J Neurosurg 2004;100:842-847.
26. Shen KR, Meyers BF, Larner JM, Jones DR: Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:290S-305S.
27. Mulvenna PM: The management of brain metastases in patients with non-small cell lung cancer-is it time to go back to the drawing board? Clin Oncol (R Coll Radiol) 2010;22:365-373.
28. Lock M, Chow E, Pond GR, et al: Prognostic factors in brain metastases: can we determine patients who do not benefit from whole-brain radiotherapy? Clin Oncol (R Coll Radiol) 2004;16:332-338.
29. Lorenzoni J, Devriendt D, Massager N, et al: Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 2004; 60:218-224.
30. Rades D, Dziggel L, Haatanen T, et al: Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases. Int J Radiat Oncol Biol Phys 2010.
31. Weltman E, Salvajoli J V, Brandt RA, et al: Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 2000;46:1155-1161.
32. Tendulkar RD, Liu S W, Barnett GH, et al: RPA classification has prognostic significance for surgically resected single brain metastasis. Int J Radiat Oncol Biol Phys 2006;66:810-817.
33. Paek SH, Audu PB, Sperling MR, Cho J, Andrews DW: Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 2005;56:1021-1034.
34. Nieder C, Bremnes RM, Andratschke NH: Prognostic scores in patients with brain metastases from non-small cell lung cancer. J Thorac Oncol 2009;4:1337-1341.
35. Hu C, Chang EL, Hassenbusch SJ 3rd, et al: Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis. Cancer 2006;106: 1998-2004.
36. Yang SY, Kim DG, Lee SH, et al: Pulmonary resection in patients with nonsmall-cell lung cancer treated with gamma-knife radiosurgery for synchronous brain metastases. Cancer 2008;112:1780-1786.
37. Paumier A, Le Pechoux C: Radiotherapy in small-cell lung cancer: where should it go? Lung Cancer 2010;69:133-140.
38. Arriagada R, Le Chevalier T, Borie F, et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 1995;87:183-190.
39. Auperin A, Arriagada R, Pignon JP, et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission: Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;341:476-484.
40. Catane R, Schwade JG, Yarr I, et al: Follow-up neurological evaluation in patients with small cell lung carcinoma treated with prophylactic cranial irradiation and chemotherapy. Int J Radiat Oncol Biol Phys 1981;7:105-109.
41. Lee JS, Umsawasdi T, Lee YY, et al: Neurotoxicity in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 1986;12:313-321.
42. Grosshans DR, Meyers CA, Allen PK, Davenport SD, Komaki R: Neurocognitive function in patients with small cell lung cancer: effect of prophylactic cranial irradiation. Cancer 2008;112:589-595.
43. Komaki R, Meyers CA, Shin DM, et al: Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995;33:179-182.
44. Sheehan J, Kondziolka D, Flickinger J, Lunsford LD: Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg 2005; 102(suppl):247-254.
45. Wegner RE, Olson AC, Kondziolka D, Niranjan A, Lundsford LD, Flickinger JC: Stereotactic radiosur-gery for patients with brain metastases from small cell lung cancer. Int J Radiat Oncol Biol Phys 2011 [Epub ahead of print].